LECTINS IN ANTI-CANCER STRATEGIES

The published during last few years data concerning communicative role of lectins (proteins and their complexes which recognize  carbohydrates, glycoconjugates and their patterns) in on-duty  supporting and increasing anticancer status of human immunity are  analyzed. Examples of lectin-(glycoconjug...

Full description

Bibliographic Details
Main Authors: M. V. Lakhtin, V. M. Lakhtin, V. A. Aleshkin, M. S. Afanasiev, S. S. Afanasiev
Format: Article
Language:Russian
Published: Scientific Сentre for Family Health and Human Reproduction Problems 2018-07-01
Series:Acta Biomedica Scientifica
Subjects:
Online Access:https://www.actabiomedica.ru/jour/article/view/652
_version_ 1826853358421409792
author M. V. Lakhtin
V. M. Lakhtin
V. A. Aleshkin
M. S. Afanasiev
S. S. Afanasiev
author_facet M. V. Lakhtin
V. M. Lakhtin
V. A. Aleshkin
M. S. Afanasiev
S. S. Afanasiev
author_sort M. V. Lakhtin
collection DOAJ
description The published during last few years data concerning communicative role of lectins (proteins and their complexes which recognize  carbohydrates, glycoconjugates and their patterns) in on-duty  supporting and increasing anticancer status of human immunity are  analyzed. Examples of lectin-(glycoconjugate pattern) strategies,  approaches and tactic variants in study and development of  anticancer treatments, principle variants of therapy, possible  vaccines in 35 cases of blood connected tumors (leukemia,  lymphomas, others), solid tumors (carcinomas, sarcoma, cancers of vaginal biotopes, prostate, bladder, colon, other intestinal  compartments, pancreas, liver, kidneys, others) and cancer cell lines  are described and systemized. The list of mostly used communicative lectins (pattern recognition receptors, their soluble forms, other  soluble lectins possessing specificities of importance) involving in key intercellular cascades and pathway co-functioning is presented. The  regulation of resulting expression of distinct active lectins (available and hetero/di/oligomeric forms) and their interaction to  adequate glycoconjugate patterns as well as influence distribution of  co-functioning lectins and antigens CD between populations and  subpopulations of antigen-presented cells (dendritic cells cDC, mDC,  moDC, pDC; macrophages M2 and M1), mucosal M-cells, NK-cells  play key role for choice and development of anticancer complex  procedures increasing innate and innate-coupled immune responses.  Prospects of (receptor lectin)-dependent intercellular  communications and targeting glycoconjugate constructions into  innate immunity cells for therapy of cancer and development of anticancer vaccines are evaluated and discussed.
first_indexed 2024-03-08T12:17:19Z
format Article
id doaj.art-b848644ad4744ae1a6a8b0fa3f45c915
institution Directory Open Access Journal
issn 2541-9420
2587-9596
language Russian
last_indexed 2025-02-16T17:24:08Z
publishDate 2018-07-01
publisher Scientific Сentre for Family Health and Human Reproduction Problems
record_format Article
series Acta Biomedica Scientifica
spelling doaj.art-b848644ad4744ae1a6a8b0fa3f45c9152025-01-27T16:48:54ZrusScientific Сentre for Family Health and Human Reproduction ProblemsActa Biomedica Scientifica2541-94202587-95962018-07-0134697710.29413/ABS.2018-3.4.11644LECTINS IN ANTI-CANCER STRATEGIESM. V. Lakhtin0V. M. Lakhtin1V. A. Aleshkin2M. S. Afanasiev3S. S. Afanasiev4G.N. Gabrichevsky Research Institute for Epidemiology and MicrobiologyG.N. Gabrichevsky Research Institute for Epidemiology and MicrobiologyG.N. Gabrichevsky Research Institute for Epidemiology and MicrobiologyThe First Sechenov Moscow State Medical UniversityG.N. Gabrichevsky Research Institute for Epidemiology and MicrobiologyThe published during last few years data concerning communicative role of lectins (proteins and their complexes which recognize  carbohydrates, glycoconjugates and their patterns) in on-duty  supporting and increasing anticancer status of human immunity are  analyzed. Examples of lectin-(glycoconjugate pattern) strategies,  approaches and tactic variants in study and development of  anticancer treatments, principle variants of therapy, possible  vaccines in 35 cases of blood connected tumors (leukemia,  lymphomas, others), solid tumors (carcinomas, sarcoma, cancers of vaginal biotopes, prostate, bladder, colon, other intestinal  compartments, pancreas, liver, kidneys, others) and cancer cell lines  are described and systemized. The list of mostly used communicative lectins (pattern recognition receptors, their soluble forms, other  soluble lectins possessing specificities of importance) involving in key intercellular cascades and pathway co-functioning is presented. The  regulation of resulting expression of distinct active lectins (available and hetero/di/oligomeric forms) and their interaction to  adequate glycoconjugate patterns as well as influence distribution of  co-functioning lectins and antigens CD between populations and  subpopulations of antigen-presented cells (dendritic cells cDC, mDC,  moDC, pDC; macrophages M2 and M1), mucosal M-cells, NK-cells  play key role for choice and development of anticancer complex  procedures increasing innate and innate-coupled immune responses.  Prospects of (receptor lectin)-dependent intercellular  communications and targeting glycoconjugate constructions into  innate immunity cells for therapy of cancer and development of anticancer vaccines are evaluated and discussed.https://www.actabiomedica.ru/jour/article/view/652malignant tumorsreceptor lectinsglycoconjugatesadjuvantscell targetingdendritic cellsmacrophagesm-cellsnk-cellscell subpopulationsinnate immunityanticancer therapyanticancer v accines
spellingShingle M. V. Lakhtin
V. M. Lakhtin
V. A. Aleshkin
M. S. Afanasiev
S. S. Afanasiev
LECTINS IN ANTI-CANCER STRATEGIES
Acta Biomedica Scientifica
malignant tumors
receptor lectins
glycoconjugates
adjuvants
cell targeting
dendritic cells
macrophages
m-cells
nk-cells
cell subpopulations
innate immunity
anticancer therapy
anticancer v accines
title LECTINS IN ANTI-CANCER STRATEGIES
title_full LECTINS IN ANTI-CANCER STRATEGIES
title_fullStr LECTINS IN ANTI-CANCER STRATEGIES
title_full_unstemmed LECTINS IN ANTI-CANCER STRATEGIES
title_short LECTINS IN ANTI-CANCER STRATEGIES
title_sort lectins in anti cancer strategies
topic malignant tumors
receptor lectins
glycoconjugates
adjuvants
cell targeting
dendritic cells
macrophages
m-cells
nk-cells
cell subpopulations
innate immunity
anticancer therapy
anticancer v accines
url https://www.actabiomedica.ru/jour/article/view/652
work_keys_str_mv AT mvlakhtin lectinsinanticancerstrategies
AT vmlakhtin lectinsinanticancerstrategies
AT vaaleshkin lectinsinanticancerstrategies
AT msafanasiev lectinsinanticancerstrategies
AT ssafanasiev lectinsinanticancerstrategies